Diagnosis and Treatment of Mucormycosis in Patients with Hematological Malignancies
-
- Asano-Mori Yuki
- Department of Hematology, Toranomon Hospital
書誌事項
- タイトル別名
-
- Diagnosis and Treatment of Mucormycosis in Patients withHematological Malignancies[Translated Article]
この論文をさがす
説明
The risk of invasive fungal infections (IFIs) is extremely high in patients with hematological malignancies due to the prolonged and profound neutropenia and immunosuppression after chemotherapy and hematopoietic stem cell transplantation. There has been increasing interest in mucormycosis despite its relatively uncommon occurrence, because occasional breakthrough infections have been observed under anti-Aspergillus prophylaxis. The aggressive nature of mucormycosis easily leads to high mortality because of delays in diagnosis and incorrect treatment decisions, which are due in part to lack of adjunctive diagnostic tools and having similar clinical and radiological features with invasive aspergillosis. The only currently available antifungals against Mucorales in Japan are amphotericin B formulations. Thus, comprehensive therapeutic strategies, including surgery, should be considered to achieve a successful outcome.
収録刊行物
-
- Medical Mycology Journal
-
Medical Mycology Journal 58 (3), E97-E105, 2017
日本医真菌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680374761088
-
- NII論文ID
- 130006035069
-
- NII書誌ID
- AA12518136
-
- ISSN
- 2186165X
- 21856486
-
- NDL書誌ID
- 028463487
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可